በOregon ለአሚሎይዶሲስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለአሚሎይዶሲስ የሚደረጉ 6 ጥናቶች በOregon ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በOregon ውስጥ ያሉ ከተሞች
Official study text (English)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Portland
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Portland
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Oregon Health & Science University, Portland
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT06563895A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Oregon Medical Research Center /ID# 255119, Portland
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ሜይ 2026 · NCT06158854Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
- Oregon Health & Science University, Portland
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ40 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT05758493MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Oregon Health and Science University (OHSU), Portland
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ27 ማርች 2026 · NCT06128629ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።